109.64
1.23%
1.095
Irhythm Technologies Inc stock is traded at $109.64, with a volume of 217.24K.
It is up +1.23% in the last 24 hours and up +21.32% over the past month.
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
See More
Previous Close:
$108.55
Open:
$107.43
24h Volume:
217.24K
Relative Volume:
0.54
Market Cap:
$3.40B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-22.56
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
+0.95%
1M Performance:
+21.32%
6M Performance:
+60.41%
1Y Performance:
-8.35%
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
109.84 | 3.40B | 560.03M | -150.66M | -87.43M | -4.86 |
ABT
Abbott Laboratories
|
128.82 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
BSX
Boston Scientific Corp
|
105.35 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
SYK
Stryker Corp
|
391.73 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
MDT
Medtronic Plc
|
89.81 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
71.04 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
Oct-04-24 | Initiated | Goldman | Neutral |
Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
Jul-19-23 | Initiated | Robert W. Baird | Outperform |
Feb-07-23 | Initiated | Wells Fargo | Overweight |
Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
Apr-06-22 | Initiated | Wolfe Research | Underperform |
Feb-24-22 | Upgrade | Needham | Hold → Buy |
Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
Dec-21-21 | Resumed | Canaccord Genuity | Buy |
Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
Jan-29-21 | Reiterated | Needham | Hold |
Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
Sep-11-20 | Initiated | Needham | Hold |
Sep-02-20 | Initiated | Robert W. Baird | Neutral |
Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
Mar-05-20 | Initiated | Citigroup | Buy |
Feb-06-20 | Initiated | BTIG Research | Buy |
Jan-10-20 | Initiated | William Blair | Outperform |
Jan-08-20 | Initiated | SunTrust | Buy |
Oct-22-19 | Initiated | Oppenheimer | Perform |
Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
SG Americas Securities LLC Has $388,000 Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
iRhythm Technologies to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation - Markets Insider
IMMINENT IRTC DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds iRhythm Technologies, Inc. Investors to Join the Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Stockholders to Connect - Markets Insider
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Exchange Traded Concepts LLC Sells 2,465 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) - MarketBeat
Is It Too Late To Consider Buying iRhythm Technologies, Inc. (NASDAQ:IRTC)? - Simply Wall St
iRhythm Technologies Board Member Steps Down for New Role - TipRanks
iRhythm Director Poul to Exit Board, Focus on Integra CEO Role - Investing.com Australia
iRhythm Director Poul to Exit Board, Focus on Integra CEO Role By Investing.com - Investing.com South Africa
Ecg Sensor Patch Market Generated Opportunities, Future Scope - openPR
How to Take Advantage of moves in (IRTC) - Stock Traders Daily
Lobbying Update: $60,000 of IRHYTHM TECHNOLOGIES INC. lobbying was just disclosed - Nasdaq
Hennion & Walsh Asset Management Inc. Has $406,000 Holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC) - Defense World
iRhythm price target raised to $125 from $112 at Needham - Yahoo Finance
What You Can Learn From iRhythm Technologies, Inc.'s (NASDAQ:IRTC) P/S - Simply Wall St
Long Term Trading Analysis for (IRTC) - Stock Traders Daily
2025-01-14 | Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Shareholders to Inquire about Securities Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies Reports Strong Growth and Innovation - Yahoo Finance
Needham & Company LLC Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price - Defense World
Analysts Set iRhythm Technologies, Inc. (NASDAQ:IRTC) Price Target at $108.45 - MarketBeat
iRhythm Technologies, Inc. (NASDAQ:IRTC) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
iRhythm Technologies (NASDAQ:IRTC) Stock Price Down 7.7%What's Next? - MarketBeat
iRhythm stock remains a Buy at Needham, target increased on sales strength - Investing.com Canada
iRhythm Technologies Shares Fall 8% Following 2024, 2025 Outlooks - MarketWatch
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $112.00 - MarketBeat
2025-01-13 | Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies expects FY24 revenue slightly above guidance range - MSN
iRhythm Technologies Shares Preliminary Fourth Quarter 2024 Highlights and Business Update at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out - AccessWire
2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out | NDAQ:IRTC | Press Release - Stockhouse Publishing
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Shareholders to Learn More About the Investigation - AccessWire
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Oppenheimer Analyst Says - Defense World
2025-01-09 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - AccessWire
Oppenheimer reiterates Outperform rating on iRhythm stock, highlighting strategic complementarity - Investing.com Australia
Vanguard Group Inc. Expands Stake in iRhythm Technologies Inc. - GuruFocus.com
iRhythm Technologies (NASDAQ:IRTC) Price Target Raised to $120.00 at Oppenheimer - MarketBeat
Oppenheimer reiterates Outperform rating on iRhythm stock, highlighting strategic complementarity By Investing.com - Investing.com South Africa
2025-01-08 | iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
The Zacks Analyst Blog Highlights Tempus AI, iRhythm Technologies and SOPHiA GENETICS - Yahoo Finance
Tempus AI Stock Surges 23% in 6 Months: Should You Snap It Up Now? - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect - AccessWire
Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation - AccessWire
2025-01-06 | Bronstein, Gewirtz & Grossman, LLC Encourages iRhythm Technologies, Inc. (IRTC) Stockholders to Inquire about Securities Investigation | NDAQ:IRTC | Press Release - Stockhouse Publishing
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Irhythm Technologies Inc Stock (IRTC) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
TALWALKAR ABHIJIT Y | Director |
Nov 04 '24 |
Buy |
75.16 |
6,664 |
500,866 |
18,941 |
Blackford Quentin S. | President and CEO |
Nov 04 '24 |
Sale |
77.41 |
16,145 |
1,249,784 |
159,929 |
Bobzien Brice | Chief Financial Officer |
Aug 09 '24 |
Sale |
70.34 |
1,372 |
96,506 |
24,428 |
Patterson Chad | Chief Commercial Officer |
May 31 '24 |
Buy |
74.98 |
280 |
20,994 |
40,145 |
Patterson Chad | Chief Commercial Officer |
Aug 02 '24 |
Sale |
74.66 |
3,012 |
224,876 |
37,133 |
Smith Mervin | EVP Strategic Business Ops |
Aug 02 '24 |
Sale |
74.66 |
688 |
51,366 |
10,360 |
Turakhia Minang | EVP, CMO & CSO |
Jul 02 '24 |
Sale |
105.65 |
1,404 |
148,333 |
27,255 |
Rosenbaum Marc W. | Chief Accounting Officer |
Jun 03 '24 |
Sale |
88.91 |
510 |
45,344 |
8,174 |
Shrishrimal Sumi | EVP, Chief Risk Officer |
Jun 03 '24 |
Sale |
88.91 |
1,131 |
100,557 |
23,298 |
Day Mark J. | Chief Technology Officer |
Mar 04 '24 |
Sale |
111.14 |
3,248 |
360,983 |
61,164 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):